Lowey Dannenberg Notifies Venture Global, Inc. (“Venture Global” or the “Company”) (NYSE: VG) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
28 févr. 2025 10h17 HE
|
Lowey Dannenberg, P.C.
NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against...
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Venture
26 févr. 2025 10h57 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Venture To Contact Him Directly To Discuss Their Options If...
Lowey Dannenberg Notifies Venture Global, Inc. (“Venture Global” or the “Company”) (NYSE: VG) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
21 févr. 2025 11h22 HE
|
Lowey Dannenberg, P.C.
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Venture
18 févr. 2025 12h44 HE
|
Faruqi & Faruqi LLP
If you purchased or otherwise acquired stock of Venture pursuant and/or traceable to Venture’s registration statement for the initial public offering held on or about January 24, 2025 and would like...
Brickeye Named to Inaugural “Foresight 50” List Of Canada’s Most Investible Cleantech Ventures
07 nov. 2024 13h01 HE
|
Brickeye
Brickeye Named to Inaugural “Foresight 50” List of Canada’s Most Investable Cleantech Ventures
SynOx Therapeutics Adds New Investor and Capital to Series B Financing, Raising Total to $92 Million, and Doses First Patients in Phase 3 Trial
30 oct. 2024 07h00 HE
|
SynOx Therapeutics Limited
Gilde Healthcare Leads Series B Extension, Joining Premier Syndicate of Leading Life Science Investors Funding Supports Registrational Phase 3 TANGENT Trial of Emactuzumab, a Best-in-Class CSF-1...
Y Innovations Group Expands Ecosystem with Yung Ventures and Y Innovations Studios
31 juil. 2024 13h10 HE
|
Y Innovations Group
BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- Y Innovations Group (“YI Group” or “the Group”) is pleased to announce the expansion of the Y Innovations ecosystem through the official launch of the Y...
gaiia Raises Series A Led by Inovia Capital to Revolutionize Customer Experience for Internet Service Providers
27 juin 2024 08h00 HE
|
gaiia
gaiia, the innovative operating system designed specifically for Internet Service Providers (ISPs), has successfully raised US$13.2M in a Series A
Regeneron Ventures Launches with $500 Million Commitment to Fuel Promising Biotechnology Innovation
15 avr. 2024 04h00 HE
|
Regeneron Ventures
GREENWICH, Conn., April 15, 2024 (GLOBE NEWSWIRE) -- Regeneron Ventures announces its formation as a venture capital fund focused on promising biopharmaceutical, health care and health technology...
SuRo Capital Corp. Fourth Quarter and Fiscal Year 2023 Preliminary Investment Portfolio Update
16 janv. 2024 16h05 HE
|
SuRo Capital Corp.
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today provided the following preliminary update on its investment...